Skip to content

The exploratory randomized controlled study on the effect of short-term acupuncture on pregnancy outcomes in patients with recurrent implantation failure during IVF-ET

Short-term acupuncture on pregnancy outcomes in patients with repeated implantation failure after IVF-ET: a pilot randomized placebo-controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000838
Enrollment
Unknown
Registered
2025-04-24
Start date
2024-09-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished Ovarian Reserve

Interventions

control group:Non penetrating false needle puncture
Experimental group:Acupuncture

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) Meeting the diagnostic criteria for infertility; 2) Patients aged = 25 years old and < 40 years old who are scheduled to undergo IVF-ET at this center; 3) Having a history of embryo transfer failure = 2 times; 4) Having a basically normal menstrual cycle and having been monitored to have normal ovulation in the past; 5) Having signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Those with endometritis acute pelvic inflammatory disease mycotic vaginitis bacterial vaginitis adnexitis or other systemic infections; 2) Those with clearly identified and severe other organic lesions in the reproductive organs; 3) Those with an allergic constitution; 4) Infertility caused by genetic factors; 5) Those with severe primary diseases of the cardiovascular and cerebrovascular systems kidneys liver hematopoietic system etc. and patients with mental illnesses; 6) Those who are unable to cooperate (such as those with neurological or mental disorders or those who are unwilling to cooperate); 7) Those with an endometrial thickness < 6mm on the human chorionic gonadotropin (HCG) day or an endometrial morphology of type C on the HCG day.

Design outcomes

Primary

MeasureTime frame
Embryo implantation rate;

Secondary

MeasureTime frame
Luteinizing hormone(LH);Clinical pregnancy rate;ß-human chorionic gonadotropin(ß-HCG);Progesterone(P);Estradiol(E2);

Countries

China

Contacts

Public ContactDong Li

Peking University Third Hospital

lidong6512@163.com15611908373

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 13, 2026